This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Regimes

Authoring team

Seek expert advice

Educate the traveler that prophylaxis is not absolute and about the importance of risk avoidance (1)

The National Travel Health Network and Centre (NaTHNaC) website provides recommended treatment options for the area to be visited

The Summaries of Product Characteristics (SmPCs) for each antimalarial agent contain the full prescribing information. The British National Formulary (BNF) covers some of the major aspects of the full prescribing information. The SmPCs and the BNF should be consulted as required when recommending malaria chemoprophylaxis

Reference:

  • Public Health England. Guidelines for malaria prevention in travellers from the UK 2019

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.